[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:dyspareunia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":30,"states":31},"Dyspareunia",3,2,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06197568","Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women",[12],"Phase 2","RECRUITING","2026-08-26T02:15:41.377360Z","2026-05-29T15:36:40.171135Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06840314","VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia",[],"2026-08-26T02:15:54.846520Z","2026-05-05T02:43:29.156039Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT07260825","Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial",[26],"Phase 2\u002FPhase 3","NOT_YET_RECRUITING","2026-08-26T02:17:27.435233Z","2026-05-05T02:43:28.727603Z",[],[]]